VIR Q2 2022 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$41M-122.9% YoY

Gross Profit

-$184M452.0% margin

Operating Income

-$225M554.3% margin

Net Income

-$76M188.3% margin

EPS (Diluted)

$-0.58

QoQ Revenue Growth

-103.3%

Cash Flow

Operating Cash Flow

$960M

Free Cash Flow

$940M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.6B

Total Liabilities

$667M

Stockholders' Equity

$2.0B

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$41M	$177M	-122.9%
Gross Profit	-$184M	$90M	-304.5%
Operating Income	-$225M	$61M	-469.1%
Net Income	-$76M	$62M	-223.7%

Revenue Segments

Contract Revenue

$12M100%